Asthma-Chronic Obstructive Pulmonary Disease Overlap

Gherasim A. Dao A. Bernstein J.A.

Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy.

World Allergy Organ J. 2018; 11: 29Raskin J. Marks T. Miller A.

Phenotypes and characterization of COPD: a pulmonary rehabilitation perspective.

J Cardiopulm Rehabil Prev. 2018; 38: 43-48Cosio B.G. Dacal D. Perez de Llano L.

Asthma-COPD overlap: identification and optimal treatment.

Ther Adv Respir Dis. 2018; 12 (1753466618805662)Sevimli N. Yapar D. Turktas H.

The Prevalence of Asthma-COPD Overlap (ACO) Among Patients with Asthma.

Turk Thorac J. 2019; 20: 97-102Hanania N.A. Chipps B.E. Griffin N.M. et al.

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.

J Allergy Clin Immunol. 2019; 143: 1629-16233 e2

Diagnosis of asthma-COPD overlap: the five commandments.

Eur Respir J. 2017; 49: 1700506

Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets.

BMJ. 2017; 358: j3772Yanagisawa S. Ichinose M.

Definition and diagnosis of asthma-COPD overlap (ACO).

Allergol Int. 2018; 67: 172-178Tu X. Donovan C. Kim R.Y. et al.

Asthma-COPD overlap: current understanding and the utility of experimental models.

Eur Respir Rev. 2021; 30: 190185McDonald V.M. Gibson P.G.

"To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.

Eur Respir J. 2017; 49: 1700336Miravitlles M. Alvarez-Gutierrez F.J. Calle M. et al.

Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.

Eur Respir J. 2017; 49: 1700068Koblizek V. Chlumsky J. Zindr V. et al.

Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013; 157: 189-201

The Asthma-COPD Overlap Syndrome.

N Engl J Med. 2015; 373: 1241-1249Bujarski S. Parulekar A.D. Sharafkhaneh A. et al.

The asthma COPD overlap syndrome (ACOS).

Curr Allergy Asthma Rep. 2015; 15: 509Barrecheguren M. Esquinas C. Miravitlles M.

The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.

Curr Opin Pulm Med. 2015; 21: 74-79de Marco R. Marcon A. Rossi A. et al.

Asthma, COPD and overlap syndrome: a longitudinal study in young European adults.

Eur Respir J. 2015; 46: 671-679Morissette M. Godbout K. Cote A. et al.

Asthma COPD overlap: Insights into cellular and molecular mechanisms.

Mol Aspects Med. 2021; 85: 101021Kubysheva N. Boldina M. Eliseeva T. et al.

Relationship of Serum Levels of IL-17, IL-18, TNF-alpha, and Lung Function Parameters in Patients with COPD, Asthma-COPD Overlap, and Bronchial Asthma.

Mediators Inflamm. 2020; 2020: 4652898

Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.

J Allergy Clin Immunol. 2016; 138: 16-27de Llano L.P. Cosio B.G. Iglesias A. et al.

Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

Int J Chron Obstruct Pulmon Dis. 2018; 13: 591-601Hikichi M. Hashimoto S. Gon Y.

Asthma and COPD overlap pathophysiology of ACO.

Allergol Int. 2018; 67: 179-186

At last - linking ORMDL3 polymorphisms, decreased sphingolipid synthesis, and asthma susceptibility.

J Clin Invest. 2020; 130: 604-607James B. Milstien S. Spiegel S.

ORMDL3 and allergic asthma: From physiology to pathology.

J Allergy Clin Immunol. 2019; 144: 634-640Christenson S.A. Steiling K. van den Berge M. et al.

Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 2015; 191: 758-766Singh U. Wangia-Anderson V. Bernstein J.A.

Chronic rhinitis is a high-risk comorbidity for 30-day hospital readmission of patients with asthma and chronic obstructive pulmonary disease.

J Allergy Clin Immunol Pract. 2019; 7: 279-285Singh S. Amin A.V. Loke Y.K.

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.

Arch Intern Med. 2009; 169: 219-229Lee S.Y. Park H.Y. Kim E.K. et al.

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.

Int J Chron Obstruct Pulmon Dis. 2016; 11: 2797-2803Su V.Y. Yang K.Y. Yang Y.H. et al.

Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma.

J Allergy Clin Immunol Pract. 2018; 6: 1927-19235 e3

Beta2-adrenoceptors: mechanisms of action of beta2-agonists.

Paediatr Respir Rev. 2001; 2: 57-62Louie S. Zeki A.A. Schivo M. et al.

The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.

Expert Rev Clin Pharmacol. 2013; 6: 197-219Yalcin A.D. Celik B. Yalcin A.N.

Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels.

Immunopharmacol Immunotoxicol. 2016; 38: 253-256

留言 (0)

沒有登入
gif